Market Research Logo

Zika Virus Testing Market: Global Industry Analysis and Opportunity Assessment 2016 - 2020

Zika Virus Testing Market: Global Industry Analysis and Opportunity Assessment 2016 - 2020

ELISA kits to be the most preferred tests for detection of Zika virus

Zika virus is a mosquito borne disease that affects pregnant women and their foetus the most. No vaccine against Zika virus has been developed yet and given the ongoing research, a cure or vaccine to treat the Zika virus remains years away. During the sudden Zika virus outbreak in 2016, there was a rapid increase in the use of POCT diagnostic tests. POCT or point of care test, does not require any laboratory setup. Any tests including RT-PCR, serology IgG/IgM Antibody detection, ELISA that may be performed without any laboratory setup can be considered as point-of-care tests. POCT tests can be performed in high risk settings, which include cases that display severe symptoms of Zika virus such as rashes in pregnancy along with fever, conjunctivitis, and muscle pain.

The research on the Zika virus point-of-care testing market considers two types of POCT tests, i.e. IgG and IgM Antibody Rapid Test and ELISA kits. According to the analysis reports, the market is expected to be dominated by ELISA kits, reaching a market size of over US$ 4,400 Mn by the end of 2020.ELISA is preferred more due to its specificity and sensitivity.The IgG/IgM Rapid Testis expected to hold a market value of just US$ 26 Mn by the end of 2020. Emergency approval of POCT testing for Zika virus screening to result in a rampant growth of test kits

The recent outbreak of Zika in Brazil, the Caribbean, the United States, Canada and various parts of Europe was caused by a more virulent viral strain from Asia. This strain traveled across the Pacific region, infecting people in island nations there, including French Polynesia. Public health officials including CDC and WHO have declared that Zika virus infection causes microcephaly and other life-threatening neurological disorders. This has increased governmental spending on the development of innovative medical diagnostic tests. Rapid IgG/IgM Zika test cards, cassettes, strips and rapid ELISA kits are the current key advanced diagnostic test kits available in the market as they have shown promising results with less sample requirement and complications associated with their usage. IgG/IgM Rapid Test is a lateral flow immunoassay for the simultaneous detection and differentiation of ZIKV in human serum and plasma. Whereas, the Zika virus ELISA (Enzyme-Linked Immunosorbent Assay) test kit detects IgM/IgG antibodies specific to Zika virus in human serum and plasma. These test kits have emerged as powerful diagnostic tools.

In Oct 2017, Chembio Diagnostics Inc. received FDA emergency use authorization (EUA) for its DPP Zika system. Similar emergencies have also been approved by the Pan American Health Organization, and this has boosted the demand for POCT tests.There has also been an increase in the spending by the U.S. FDA as well as the Brazilian government to add the Zika Screening Program across all the hospitals and blood banks in America. Many organisations are also focusing on increasing national awareness campaigns about the Zika spread. These factors may further generate more revenue for the Zika virus point-of-care testing market.


1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Zika Virus Testing Market View Point
Tracking the market scenario, with key inferences drawn from historical data, current trends, and future prospects
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Technology Evolution
4.2. List of Growth Hacking Manufacturers
4.3. Value Chain
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity Analysis
4.5. Reimbursement Landscape
4.6. Regulatory Scenario
5. Macroeconomic Assumptions
6. Global Economic Outlook
6.1. Gross Domestic Product by Region & Country, 2006 – 2021
6.2. Disease Outlook
7. Key Inclusions
7.1. Key Distributor List
7.2. Key Mergers & Acquisitions
8. North America Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
Analysis highlighting historical trends, current market value, and future projections on the basis of key segments
8.1. Introduction
8.2. Key Takeaways
8.3. Regional Market Trends
8.4. U.S. Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
8.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2012–2016
8.4.1.1. Hospitals & Clinics
8.4.1.2. Private Commercial Laboratories
8.4.1.3. Government/ Publicly Funded Programs
8.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2017–2027
8.4.3. Pricing Analysis
8.4.4. Government Initiatives and Spending Scenario
8.4.5. Key Competition Mapping
8.5. Market Attractiveness Analysis
8.5.1. By End User
8.6. Key Market Participants – Intensity Mapping
9. Europe Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
Analysis highlighting historical trends, current market value, and future projections on the basis of key segments
9.1. Introduction
9.2. Key Takeaways
9.3. Regional Market Trends
9.4. Germany Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
9.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2012–2016
9.4.1.1. Hospitals & Clinics
9.4.1.2. Private Commercial Laboratories
9.4.1.3. Government/ Publicly Funded Programs
9.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2017–2027
9.4.3. Pricing Analysis
9.4.4. Government Initiatives and Spending Scenario
9.4.5. Key Competition Mapping
9.5. United Kingdom Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
9.5.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2012–2016
9.5.1.1. Hospitals & Clinics
9.5.1.2. Private Commercial Laboratories
9.5.1.3. Government/ Publicly Funded Programs
9.5.2. Market Size (US$ Mn) & Volume Forecast By End User, 2017–2027
9.5.3. Pricing Analysis
9.5.4. Government Initiatives and Spending Scenario
9.5.5. Key Competition Mapping
9.6. France Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
9.6.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2012–2016
9.6.1.1. Hospitals & Clinics
9.6.1.2. Private Commercial Laboratories
9.6.1.3. Government/ Publicly Funded Programs
9.6.2. Market Size (US$ Mn) & Volume Forecast By End User, 2017–2027
9.6.3. Pricing Analysis
9.6.4. Government Initiatives and Spending Scenario
9.6.5. Key Competition Mapping
9.7. Italy Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
9.7.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2012–2016
9.7.1.1. Hospitals & Clinics
9.7.1.2. Private Commercial Laboratories
9.7.1.3. Government/ Publicly Funded Programs
9.7.2. Market Size (US$ Mn) & Volume Forecast By End User, 2017–2027
9.7.3. Pricing Analysis
9.7.4. Government Initiatives and Spending Scenario
9.7.5. Key Competition Mapping
9.8. Spain Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
9.8.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2012–2016
9.8.1.1. Hospitals & Clinics
9.8.1.2. Private Commercial Laboratories
9.8.1.3. Government/ Publicly Funded Programs
9.8.2. Market Size (US$ Mn) & Volume Forecast By End User, 2017–2027
9.8.3. Pricing Analysis
9.8.4. Government Initiatives and Spending Scenario
9.8.5. Key Competition Mapping
9.9. Market Attractiveness Analysis
9.9.1. By Country
9.9.2. By End User
9.10. Key Market Participants – Intensity Mapping
10. Caribbean Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
Analysis highlighting historical trends, current market value, and future projections on the basis of key segments
10.1. Introduction
10.2. Key Takeaways
10.3. Regional Market Trends
10.4. Puerto Rico Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
10.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2012–2016
10.4.1.1. Hospitals & Clinics
10.4.1.2. Private Commercial Laboratories
10.4.1.3. Government/ Publicly Funded Programs
10.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2017–2027
10.4.3. Pricing Analysis
10.4.4. Government Initiatives and Spending Scenario
11. Latin America Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
Analysis highlighting historical trends, current market value, and future projections on the basis of key segments
11.1. Introduction
11.2. Key Takeaways
11.3. Regional Market Trends
11.4. Brazil Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
11.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2012–2016
11.4.1.1. Hospitals & Clinics
11.4.1.2. Private Commercial Laboratories
11.4.1.3. Government/ Publicly Funded Programs
11.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2017–2027
11.4.3. Pricing Analysis
11.4.4. Government Initiatives and Spending Scenario
11.5. Mexico Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
11.5.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2012–2016
11.5.1.1. Hospitals & Clinics
11.5.1.2. Private Commercial Laboratories
11.5.1.3. Government/ Publicly Funded Programs
11.5.2. Market Size (US$ Mn) & Volume Forecast By End User, 2017–2027
11.5.3. Pricing Analysis
11.5.4. Government Initiatives and Spending Scenario
11.6. Columbia Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
11.6.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2012–2016
11.6.1.1. Hospitals & Clinics
11.6.1.2. Private Commercial Laboratories
11.6.1.3. Government/ Publicly Funded Programs
11.6.2. Market Size (US$ Mn) & Volume Forecast By End User, 2017–2027
11.6.3. Pricing Analysis
11.6.4. Government Initiatives and Spending Scenario
11.7. Market Attractiveness Analysis
11.7.1. By Country
11.7.2. By End User
11.8. Key Market Participants – Intensity Mapping
12. Central America Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
Analysis highlighting historical trends, current market value, and future projections on the basis of key segments
12.1. Introduction
12.2. Key Takeaways
12.3. Regional Market Trends
12.4. Central America Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
12.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2012–2016
12.4.1.1. Hospitals & Clinics
12.4.1.2. Private Commercial Laboratories
12.4.1.3. Government/ Publicly Funded Programs
12.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2017–2027
12.4.3. Pricing Analysis
12.4.4. Government Initiatives and Spending Scenario
12.5. Key Competition Mapping
12.6. Market Attractiveness Analysis
12.6.1. By End User
12.7. Key Market Participants – Intensity Mapping
13. South-East Asia Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
Analysis highlighting historical trends, current market value, and future projections on the basis of key segments
13.1. Introduction
13.2. Key Takeaways
13.3. Regional Market Trends
13.4. Indonesia Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
13.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2012–2016
13.4.1.1. Hospitals & Clinics
13.4.1.2. Private Commercial Laboratories
13.4.1.3. Government/ Publicly Funded Programs
13.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2017–2027
13.4.3. Pricing Analysis
13.4.4. Government Initiatives and Spending Scenario
13.5. Thailand Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
13.5.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2012–2016
13.5.1.1. Hospitals & Clinics
13.5.1.2. Private Commercial Laboratories
13.5.1.3. Government/ Publicly Funded Programs
13.5.2. Market Size (US$ Mn) & Volume Forecast By End User, 2017–2027
13.5.3. Pricing Analysis
13.5.4. Government Initiatives and Spending Scenario
13.6. Singapore Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
13.6.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2012–2016
13.6.1.1. Hospitals & Clinics
13.6.1.2. Private Commercial Laboratories
13.6.1.3. Government/ Publicly Funded Programs
13.6.2. Market Size (US$ Mn) & Volume Forecast By End User, 2017–2027
13.6.3. Pricing Analysis
13.6.4. Government Initiatives and Spending Scenario
13.7. Vietnam Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
13.7.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2012–2016
13.7.1.1. Hospitals & Clinics
13.7.1.2. Private Commercial Laboratories
13.7.1.3. Government/ Publicly Funded Programs
13.7.2. Market Size (US$ Mn) & Volume Forecast By End User, 2017–2027
13.7.3. Pricing Analysis
13.7.4. Government Initiatives and Spending Scenario
13.8. Key Competition Mapping
13.9. Market Attractiveness Analysis
13.9.1. By Country
13.9.2. By End User
13.10. Key Market Participants – Intensity Mapping
14. Rest of the World Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
Analysis highlighting historical trends, current market value, and future projections on the basis of key segments
14.1. Introduction
14.2. Key Takeaways
14.3. Regional Market Trends
14.4. North Africa Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
14.4.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2012–2016
14.4.1.1. Hospitals & Clinics
14.4.1.2. Private Commercial Laboratories
14.4.1.3. Government/ Publicly Funded Programs
14.4.2. Market Size (US$ Mn) & Volume Forecast By End User, 2017–2027
14.4.3. Pricing Analysis
14.4.4. Government Initiatives and Spending Scenario
14.5. South Africa Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
14.5.1. Historical Market Size (US$ Mn) & Volume Trend Analysis By End User, 2012–2016
14.5.1.1. Hospitals & Clinics
14.5.1.2. Private Commercial Laboratories
14.5.1.3. Government/ Publicly Funded Programs
14.5.2. Market Size (US$ Mn) & Volume Forecast By End User, 2017–2027
14.5.3. Pricing Analysis
14.5.4. Government Initiatives and Spending Scenario
14.6. Key Competition Mapping
14.7. Market Attractiveness Analysis
14.7.1. By Country
14.7.2. By End User
14.8. Key Market Participants – Intensity Mapping
15. Forecast Factors: Relevance and Impact
16. Forecast Assumptions
17. Market Structure Analysis
17.1. Market Structure by Tier of Companies
17.2. Market Share Analysis (2016) for Top 10 Players, By Region
17.3. Production Capacity Analysis, By Key Players
17.4. Pricing Analysis By Key Players, By Region
18. Competition Analysis
Company Deep Dive Profile of some of the key market players, with specific focus on business and Zika Virus Testing Market
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Profitability and Gross Margin Analysis By Competition
18.4. Company Deep Dive
18.4.1. EUROIMMUN US, Inc.
18.4.1.1. Overview
18.4.1.2. Product and Application Portfolio
18.4.1.3. Production Footprint
18.4.1.4. Sales Footprint
18.4.1.5. Channel Footprint
18.4.1.6. Strategy
18.4.1.6.1. Marketing Strategy
18.4.1.6.2. Product Strategy
18.4.1.6.3. Channel Strategy
18.4.2. Creative Diagnostics
18.4.2.1. Overview
18.4.2.2. Product and Application Portfolio
18.4.2.3. Production Footprint
18.4.2.4. Sales Footprint
18.4.2.5. Channel Footprint
18.4.2.6. Strategy
18.4.2.6.1. Marketing Strategy
18.4.2.6.2. Product Strategy
18.4.2.6.3. Channel Strategy
18.4.3. Quest Diagnostics
18.4.3.1. Overview
18.4.3.2. Product and Application Portfolio
18.4.3.3. Production Footprint
18.4.3.4. Sales Footprint
18.4.3.5. Channel Footprint
18.4.3.6. Strategy
18.4.3.6.1. Marketing Strategy
18.4.3.6.2. Product Strategy
18.4.3.6.3. Channel Strategy
18.4.4. Artron Laboratories Inc.
18.4.4.1. Overview
18.4.4.2. Product and Application Portfolio
18.4.4.3. Production Footprint
18.4.4.4. Sales Footprint
18.4.4.5. Channel Footprint
18.4.4.6. Strategy
18.4.4.6.1. Marketing Strategy
18.4.4.6.2. Product Strategy
18.4.4.6.3. Channel Strategy
18.4.5. RapiGEN Inc.
18.4.5.1. Overview
18.4.5.2. Product and Application Portfolio
18.4.5.3. Production Footprint
18.4.5.4. Sales Footprint
18.4.5.5. Channel Footprint
18.4.5.6. Strategy
18.4.5.6.1. Marketing Strategy
18.4.5.6.2. Product Strategy
18.4.5.6.3. Channel Strategy
18.4.6. GenBody Inc.
18.4.6.1. Overview
18.4.6.2. Product and Application Portfolio
18.4.6.3. Production Footprint
18.4.6.4. Sales Footprint
18.4.6.5. Channel Footprint
18.4.6.6. Strategy
18.4.6.6.1. Marketing Strategy
18.4.6.6.2. Product Strategy
18.4.6.6.3. Channel Strategy
18.4.7. JAJ International, Inc.
18.4.7.1. Overview
18.4.7.2. Product and Application Portfolio
18.4.7.3. Production Footprint
18.4.7.4. Sales Footprint
18.4.7.5. Channel Footprint
18.4.7.6. Strategy
18.4.7.6.1. Marketing Strategy
18.4.7.6.2. Product Strategy
18.4.7.6.3. Channel Strategy
18.4.8. LumiQuick Diagnostics, Inc.
18.4.8.1. Overview
18.4.8.2. Product and Application Portfolio
18.4.8.3. Production Footprint
18.4.8.4. Sales Footprint
18.4.8.5. Channel Footprint
18.4.8.6. Strategy
18.4.8.6.1. Marketing Strategy
18.4.8.6.2. Product Strategy
18.4.8.6.3. Channel Strategy
18.4.9. Biocan Diagnostics Inc.
18.4.9.1. Overview
18.4.9.2. Product and Application Portfolio
18.4.9.3. Production Footprint
18.4.9.4. Sales Footprint
18.4.9.5. Channel Footprint
18.4.9.6. Strategy
18.4.9.6.1. Marketing Strategy
18.4.9.6.2. Product Strategy
18.4.9.6.3. Channel Strategy
18.4.10. NECTAR LIFESCIENCES LTD.
18.4.10.1. Overview
18.4.10.2. Product and Application Portfolio
18.4.10.3. Production Footprint
18.4.10.4. Sales Footprint
18.4.10.5. Channel Footprint
18.4.10.6. Strategy
18.4.10.6.1. Marketing Strategy
18.4.10.6.2. Product Strategy
18.4.10.6.3. Channel Strategy
19. Global Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027 By Region
19.1. Introduction / Key Findings
19.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
19.2.1. North America
19.2.2. Western Europe
19.2.3. Eastern Europe
19.2.4. Latin America
19.2.5. Central America
19.2.6. Asia Pacific Excluding Japan
19.2.7. Japan
19.2.8. Rest of World
19.3. Market Size (US$ Mn) Forecast By Region, 2017–2027
19.4. Market Attractiveness Analysis By Region
20. Global Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027, By End User
20.1. Introduction/Key Findings
20.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By End User, 2012–2016
20.2.1. Hospital Pharmacies
20.2.2. Retail Pharmacies and Drug Stores
20.2.3. Online Sales
20.2.4. Other
20.3. Market Size (US$ Mn) and Volume Forecast By End User, 2017–2027
20.4. Market Attractiveness Analysis By End User
21. Global Zika Virus Testing Market Analysis 2012–2016 and Forecast 2017–2027
21.1.Market Value Share Analysis, By All Segment
21.2.Y-o-Y Growth Analysis, By All Segment
21.3.Absolute $ Opportunity
22. Assumptions and Acronyms Used
A glossary of assumption and acronyms used in the report

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report